Alveo, AGBL Ink Deal to Expand Bird Flu Testing Across Africa, Asia
Image
Alameda – September 17, 2026 -- Alveo Technologies has signed a distribution agreement with Alliance Global (AGBL) to deploy its on-farm avian influenza diagnostic across Africa, Central Asia and select Eastern Mediterranean countries, as global bird flu outbreaks have infected at least 633 million domestic birds worldwide, including more than 208 million in the U.S. alone.
Alveo Sense Poultry gains distribution rights across three continents
Under the deal, AGBL secures rights to distribute Alveo's palm-sized molecular diagnostic platform to farmers, integrators and public health officials throughout Africa, Central Asia and portions of the Eastern Mediterranean region. AGBL operates as a biomedical distribution group with offices in more than 17 countries across the Middle East, Africa and Asia.